go back

Brexucabtagene Autoleucel (Tecartus) CAR-T Therapy

Kentucky rates for HCPCS Q2053

Brexucabtagene autoleucel, up to 200 million autologous anti-CD19 CAR positive viable T cells, including leukapheresis and dose preparation procedures, per therapeutic dose

Rates data updated July 2026.

Facilitymedian $575,440 · 10th–90th $489,779$575,4400%50%10th$575,440Professionalmedian $489,779 · 10th–90th $489,779$691,8310%50%90th$489,779$0.0$0.5$10.0$200.0$5.0K$100.0K$2.0M

Distribution of negotiated rates across all payers (price axis is log-scale). Facility and professional rates are different services and are charted separately. Need provider-level prices? Contact us.

Insurance Carrier
Aetna
Setting
Facility
Modifier
Global
Typical Low
$489,778.82
Median
$489,778.82
Typical High
$831,763.77
Aetna
Setting
Professional
Modifier
Global
Typical Low
$489,778.82
Median
$489,778.82
Typical High
$691,830.97
Anthem BCBS
Setting
Facility
Modifier
Global
Typical Low
$0.03
Median
$575,439.94
Typical High
$575,439.94
Anthem BCBS
Setting
Professional
Modifier
Global
Typical Low
$489,778.82
Median
$489,778.82
Typical High
$489,778.82
CareSource
Setting
Facility
Modifier
Global
Typical Low
$489,778.82
Median
$489,778.82
Typical High
$776,247.12
CareSource
Setting
Professional
Modifier
Global
Typical Low
$489,778.82
Median
$512,861.38
Typical High
$691,830.97
Molina
Setting
Professional
Modifier
Global
Typical Low
$5,011.87
Median
$5,011.87
Typical High
$5,011.87
United
Setting
Facility
Modifier
Global
Typical Low
$489,778.82
Median
$489,778.82
Typical High
$489,778.82
United
Setting
Professional
Modifier
Global
Typical Low
$363,078.05
Median
$467,735.14
Typical High
$537,031.80